Wei et al., 2022 - Google Patents
Calcium-containing versus calcium-free replacement solution in regional citrate anticoagulation for continuous renal replacement therapy: a randomized controlled …Wei et al., 2022
View PDF- Document ID
- 839906231462389040
- Author
- Wei T
- Tang X
- Zhang L
- Lin L
- Li P
- Wang F
- Fu P
- Publication year
- Publication venue
- Chinese Medical Journal
External Links
Snippet
Background: A simplified protocol for regional citrate anticoagulation (RCA) using a commercial calcium-containing replacement solution, without continuous calcium infusion, is more efficient for use in continuous renal replacement therapy (CRRT). We aim to design a …
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [Ca] 0 title abstract description 120
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3424—Substitution fluid path
- A61M1/3437—Substitution fluid path downstream the filter, e.g. post-dilution with filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3455—Substitution fluids
- A61M1/3458—Substitution fluids having electrolytes not present in the dialysate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes
- A61M1/1692—Detection of blood traces in dialysate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3672—Means preventing coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3601—Extra-corporeal circuits in which the blood fluid passes more than once through the treatment unit
- A61M1/3603—Extra-corporeal circuits in which the blood fluid passes more than once through the treatment unit in the same direction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tolwani et al. | A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance | |
| Alvarez et al. | Renal replacement therapy: a practical update | |
| AU2010230239B2 (en) | A multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit | |
| del Castillo et al. | Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study | |
| Giani et al. | Continuous renal replacement therapy in venovenous extracorporeal membrane oxygenation: a retrospective study on regional citrate anticoagulation | |
| Gashti et al. | Membrane‐based therapeutic plasma exchange (mTPE): technical and clinical experience | |
| Rico et al. | Regional citrate anticoagulation for continuous renal replacement therapy in children | |
| Tangvoraphonkchai et al. | Platelet activation and clotting cascade activation by dialyzers designed for high volume online hemodiafiltration | |
| Wright et al. | Citrate anticoagulation using ACD solution A during long‐term haemodialysis | |
| Claure‐Del Granado et al. | Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD) | |
| Wei et al. | Calcium-containing versus calcium-free replacement solution in regional citrate anticoagulation for continuous renal replacement therapy: a randomized controlled trial | |
| Liet et al. | Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions | |
| Francey et al. | Regional citrate anticoagulation for intermittent hemodialysis in dogs | |
| Förster et al. | Plasma exchange in severe postpartum HELLP syndrome | |
| MacEwen et al. | Circuit life versus bleeding risk: the impact of achieved activated partial thromboplastin time versus achieved filtration fraction | |
| Vandenbosch et al. | Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study | |
| Khadzhynov et al. | Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19 | |
| Sahota et al. | Inpatient hemodialysis without anticoagulation in adults | |
| McGill et al. | Clinical consequences of heparin‐free hemodialysis | |
| Ma et al. | Good Tolerance of Citrate Accumulation due to Plasma Exchange among Patients with Acute‐on‐Chronic Liver Failure: A Prospective, Observational Study | |
| Lenga et al. | Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis | |
| Frascà et al. | Post‐Dilution Hemodiafiltration With a Heparin‐Grafted Polyacrylonitrile Membrane | |
| Farah et al. | Combination hemodialysis and centrifugal therapeutic plasma exchange: 18 years of C anadian experience | |
| Krummel et al. | Hemodialysis without anticoagulation: less clotting in conventional hemodialysis than in predilution hemodiafiltration | |
| Leung et al. | Citrate vs. acetate dialysate on intradialytic heparin dose: a double blind randomized crossover study |